The Food and Drug Administration today recommended medical device manufacturers, health care providers and patients take certain actions to reduce the risk that a remote attacker could exploit a set of cybersecurity vulnerabilities to control a medical device or prevent it from functioning. The agency to date has not received any adverse event reports associated with the vulnerabilities, announced in a July advisory from the Department of Homeland Security. The vulnerabilities exist in IPnet, a third-party software component that supports network communications between computers. The software is part of several operating systems and may be used in a wide range of medical and industrial devices.
 

Related News Articles

Headline
Microsoft has released a security update to address a critical remote code execution vulnerability impacting multiple versions of Windows Server Update…
Headline
In part two of a recent blog, AHA National Advisor for Cybersecurity and Risk John Riggi and AHA Deputy National Advisor for Cybersecurity and Risk Scott Gee…
AHA Cyber Intel
In part one of this blog, we reviewed the number of cyberattacks the health care field endured this year compared to last; provided an overview of the lessons…
Headline
The Cybersecurity and Infrastructure Security Agency Oct. 15 released an emergency directive advising federal agencies to take stock of their F5 BIG-IP…
Headline
In part one of a new blog, John Riggi, AHA national advisor for cybersecurity and risk, and Scott Gee, AHA deputy national advisor for cybersecurity and risk,…
Headline
The Food and Drug Administration has identified a Class I recall of Abiomed Automated Impella Controllers due to the potential for serious injury or death. The…